Stifel Financial
FOMX

Stifel Financial’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Stifel Financial’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-23,000
Closed -$77K – 3198
2019
Q4 		$77K Buy
23,000
+5,000
+28% +$15.9K ﹤0.01% 2906
2019
Q3 		$54K Buy
+18,000
New +$50.6K ﹤0.01% 2798

Stifel Financial's FOMX Position: Q1 2020 in Review

Stifel Financial sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 23,000 shares — an estimated $77K sold.

Stifel Financial first reported a position in FOMX in Q3 2019 and held it in 2 quarters. The position peaked at $77K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Stifel Financial reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Stifel Financial sold 23,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $77K.
  • Stifel Financial first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2019 and held it in 2 quarters.
  • Stifel Financial's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $77K in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Stifel Financial's 13F filing for Q1 2020, filed 14 May 2020.